CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Tipo de material:
TextoSeries ; Nature Medicine, 24, p.927-930, 2018Trabajos contenidos: - Haapaniemi, E
- Botla, S
- Persson, J
- Schmierer, B
- Taipale, J
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Documentos solicitados
|
CICY Documento préstamo interbibliotecario | Ref1 | B-17141 (Browse shelf(Opens below)) | Available |
Here, we report that genome editing by CRISPR-Cas9 induces a p53-mediated DNA damage response and cell cycle arrest in immortalized human retinal pigment epithelial cells, leading to a selection against cells with a functional p53 pathway. Inhibition of p53 prevents the damage response and increases the rate of homologous recombination from a donor template. These results suggest that p53 inhibition may improve the efficiency of genome editing of untransformed cells and that p53 function should be monitored when developing cell-based therapies utilizing CRISPR-Cas9.
There are no comments on this title.
